NCT06655233View on ClinicalTrials.gov

Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

May 30, 2026

Conditions
Pancreatic CancerEUS-FNBIntratumoral MicrobiotaDiagnosisPrognosis
Trial Locations (1)

410000

RECRUITING

The Third Xiangya Hospital of Central South University, Hunan

All Listed Sponsors
lead

The Third Xiangya Hospital of Central South University

OTHER